Souza, Luiz Paulo Chaves de; Melo, Camila Morais 
; Saggioro, Fabiano Pinto ; Reis, Rodolfo Borges dos ; Squire, Jeremy Andrew
Source: Genes. Unidades: SVOI, FMRP
Subjects: NEOPLASIAS PROSTÁTICAS, IMUNOTERAPIA, ONCOGENES, GENES SUPRESSORES DE TUMOR, MUTAÇÃO GENÉTICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Luiz Paulo Chaves de et al. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics. Genes, v. 12, n. 12, p. 1-18, 2021Tradução . . Disponível em: https://doi.org/10.3390/genes12121900. Acesso em: 28 jul. 2024.APA
Souza, L. P. C. de, Melo, C. M., Saggioro, F. P., Reis, R. B. dos, & Squire, J. A. (2021). Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics. Genes, 12( 12), 1-18. doi:10.3390/genes12121900NLM
Souza LPC de, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics [Internet]. Genes. 2021 ; 12( 12): 1-18.[citado 2024 jul. 28 ] Available from: https://doi.org/10.3390/genes12121900Vancouver
Souza LPC de, Melo CM, Saggioro FP, Reis RB dos, Squire JA. Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics [Internet]. Genes. 2021 ; 12( 12): 1-18.[citado 2024 jul. 28 ] Available from: https://doi.org/10.3390/genes12121900
